Julia A. Haller
Experienced in Leber Hereditary Optic Neuropathy (LHON)

Dr. Julia A. Haller

Ophthalmology
840 Walnut Street, Floor 10, 
Philadelphia, PA 
Accepting New Patients
Experienced in Leber Hereditary Optic Neuropathy (LHON)
840 Walnut Street, Floor 10, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Julia Haller is an Ophthalmologist in Philadelphia, Pennsylvania. Dr. Haller is rated as an Experienced provider by MediFind in the treatment of Leber Hereditary Optic Neuropathy (LHON). Her top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal. Dr. Haller is currently accepting new patients.

Her clinical research consists of co-authoring 327 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has participated in 2 clinical trials in the study of Leber Hereditary Optic Neuropathy (LHON).

Graduate Institution
Harvard Medical School
Residency
Wilmer Eye Institute
Specialties
Ophthalmology
Licenses
Ophthalmology in PA
Board Certifications
Ophthalmology
Fellowships
Wilmer Eye Institute
Manhattan Eye, Ear & Throat Institute
Hospital Affiliations
Thomas Jefferson University Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northwell Health
  • INSURANCE PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Ophthalmology - Wills Eye Hospital
840 Walnut Street, Floor 10, Philadelphia, PA 19107

Additional Areas of Focus

Dr. Haller has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Retinitis Pigmentosa
Retinoblastoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
Enrollment Status: Completed
Publish Date: August 22, 2022
Intervention Type: Other
Study Phase: Not Applicable
A Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for 6 Months or Less by LHON Due to the G11778A Mutation in the Mitochondrial ND4 Gene
A Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for 6 Months or Less by LHON Due to the G11778A Mutation in the Mitochondrial ND4 Gene
Enrollment Status: Completed
Publish Date: July 29, 2022
Intervention Type: Biological, Device
Study Phase: Phase 3
Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for More Than 6 Months and To 12 Months by LHON Due to the G11778A Mutation in the ND4 Gene
Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for More Than 6 Months and To 12 Months by LHON Due to the G11778A Mutation in the ND4 Gene
Enrollment Status: Completed
Publish Date: January 23, 2020
Intervention Type: Biological, Device
Study Phase: Phase 3
View 2 Less Clinical Trials

327 Total Publications

Search for the Rare Decay D^{0}→μ^{+}μ^{-} in Proton-Proton Collisions at sqrt[s]=13.6  TeV.
Search for the Rare Decay D^{0}→μ^{+}μ^{-} in Proton-Proton Collisions at sqrt[s]=13.6  TeV.
Journal: Physical review letters
Published: June 06, 2025
Similar Doctors
Elite in Leber Hereditary Optic Neuropathy (LHON)
Dr. Mark L. Moster
Ophthalmology | Neurology
Elite in Leber Hereditary Optic Neuropathy (LHON)
Dr. Mark L. Moster
Ophthalmology | Neurology
840 Walnut St Ste 930, 
Philadelphia, PA 
 (0.3 miles away)
215-928-3130
Languages Spoken:
English
See accepted insurances

Mark Moster is an Ophthalmologist and a Neurologist in Philadelphia, Pennsylvania. Dr. Moster is rated as an Elite provider by MediFind in the treatment of Leber Hereditary Optic Neuropathy (LHON). His top areas of expertise are Leber Hereditary Optic Neuropathy (LHON), Optic Nerve Atrophy, Papilledema, Temporal Arteritis, and Vitrectomy.

Robert C. Sergott
Elite in Leber Hereditary Optic Neuropathy (LHON)
Dr. Robert C. Sergott
Ophthalmology
Elite in Leber Hereditary Optic Neuropathy (LHON)
Dr. Robert C. Sergott
Ophthalmology

Ophthalmology - Wills Eye Hospital

840 Walnut Street, Floor 10, 
Philadelphia, PA 
 (0.1 miles away)
215-928-3130
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Sergott is an Ophthalmologist in Philadelphia, Pennsylvania. Dr. Sergott is rated as a Distinguished provider by MediFind in the treatment of Leber Hereditary Optic Neuropathy (LHON). His top areas of expertise are Optic Nerve Atrophy, Leber Hereditary Optic Neuropathy (LHON), Papilledema, and Optic Neuritis. Dr. Sergott is currently accepting new patients.

Elite in Leber Hereditary Optic Neuropathy (LHON)
Dr. Bart P. Leroy
Ophthalmology
Elite in Leber Hereditary Optic Neuropathy (LHON)
Dr. Bart P. Leroy
Ophthalmology
34th & Civic Center Blvd, Children's Hospital Of Philadelphia, 
Philadelphia, PA 
 (2.1 miles away)
215-590-2791
Languages Spoken:
English

Bart Leroy is an Ophthalmologist in Philadelphia, Pennsylvania. Dr. Leroy is rated as an Elite provider by MediFind in the treatment of Leber Hereditary Optic Neuropathy (LHON). His top areas of expertise are Leber Congenital Amaurosis, Retinopathy Pigmentary Mental Retardation, Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Haller's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 13 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile